Markets:

Overview

News

Currencies

International

Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

0.7630 -0.0392 (-4.89%)

Delayed Quote Updated: 10:17 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karyopharm Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

These stocks that are showing activity before the opening bell on Wednesday. ↗

October 08, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 23, 2025

Via Benzinga

Earnings Outlook For Karyopharm Therapeutics ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Earnings Scheduled For February 19, 2025 ↗

February 19, 2025

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session. ↗

August 15, 2025

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 11, 2025

Via Benzinga

Karyopharm Therapeutics's Earnings: A Preview ↗

February 28, 2024

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results ↗

May 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 23, 2025

Via Benzinga

Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

April 08, 2025

Via Benzinga

What's going on in today's session ↗

February 26, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Here are the top movers in Wednesday's session. ↗

February 26, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

February 26, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

Karyopharm Therapeutics (KPTI) Q4 2024 Earnings Call Transcript ↗

February 19, 2025

KPTI earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket ↗

December 16, 2024

Via Benzinga

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript ↗

November 05, 2024

KPTI earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 30, 2024

Via Benzinga

Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript ↗

August 06, 2024

KPTI earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom ↗

May 23, 2024

These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress.

Via InvestorPlace

Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript ↗

May 08, 2024

KPTI earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript ↗

February 29, 2024

KPTI earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.